Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 911-915-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
In a Segment I, II and III approach, which in general cover all aspects investigated in developmental and one generation studies, the NOAEL for developmental toxicity, as well as reproductive and fertility performance of Olaflur was established to be at 25 mg/kg bw/day. There were no adverse effects attributable to Olaflur, only some slight toxic effects occurred. Thus, the NOAEL for reproductive toxicity by far exceeds the NOAEL for systemic toxicity derived from a chronic toxicity study and clearly indicates that Olaflur does not represent a specific concern with regard to reproductive or developmental toxicity.
Effect on fertility: via oral route
- Dose descriptor:
- NOAEL
- 25 mg/kg bw/day
Additional information
Key Studies:
Segment I rat fertility study:
In a reproduction / fertility toxicity study Amine fluorides 297/242 (mixture of 1.315 % Olaflur as leading substance and 0.347 % Hetaflur) were administered orally to sexually mature male and female Long-Evans rats (10 males, 20 females per dose) from prior to mating to the time of sacrifice at dose levels of 0, 1, 5, and 25 mg/kg bw/day at a volume of 10 mL /kg bw/day in a vehicle of 0.25% methylcellulose. The control group received the vehicle only (Menley & James Laboratories, 1973).
The NOEL is considered to be 25 mg/kg bw/day for both males and females.
There were no adverse effects which could be attributed to amine fluoride 297/242 as evidenced in evaluations of female body weights and weight gains, adult mortality, mating performances, oestrous cycles, pregnancy rates, lengths of gestation, implantation efficiencies, numbers of implantations or litter size. Evaluations of postnatal offspring viabilities, litter survivals, offspring weights, sex ratios and incidences of malformations showed no adverse effects attributable to amine fluoride 297/242 administration. There were statistically significant (p < 0.05) higher incidences of apparent intrauterine deaths in the mid and high-dose groups. These findings were adjudged to be the results of experimental sampling and of little toxicological significance.
Seg III, rat
In a Seg III developmental toxicity study (Menley & James 1973) Amine fluorides 297/242 were administered orally to mated Long-Evans rats from day 15 of gestation through day 21 of lactation. Dose levels of 1.0, 5.0, and 25.0 mg/kg bw/day were administered at a volume of 10 mL/kg bw/day in a vehicle of 0.25 % methylcellulose. The control group received the vehicle only.
There were no adverse effects upon pregnancy rate, maternal mortality, prenatal or postnatal offspring viability, percent of litters weaned, mean offspring weights., sex ratios, or soft-tissue malformations. Some slight effects concerning intrauterine deaths and postnatal viability were observed, however, these effects are considered to be not dose dependent or test item related.
Developmental, rat (2 generations)
In a developmental toxicity study (LTP, 2005) Olaflur (Amine fluoride 297 -103) was administered to pregnant CD/Crl:CD rats (20 /group, F0 -generation) by oral gavage at dose levels of 0, 6, 20 or 60 mg/kg bw/day from implantation (6th day of gestation) until weaning (the 21st day of lactation). After spontaneous delivery the F1-generation animals were examined and their development was observed employing parameters such as body weight gain, morphological landmarks and functional tests. Dams which did not deliver spontaneously were laparotomised on the 3rd day after the calculated day of delivery. The uterus was examined macroscopically and the implantation sites were determined. One male and one female rat of each litter and group (F1-generation; with a body weight nearest to the mean litter weight) were raised to maturity and mated at the age of 13 weeks. The males were sacrificed after the mating period. After spontaneous delivery, the pups (F2-generation) were weaned and their development was observed employing body weight gain. Dams which did not deliver spontaneously were laparotomised on the 3rd day after the calculated day of delivery. The uterus was examined macroscopically and the implantation sites were determined. The dams and pups were sacrificed after 3 lactation weeks.
The NOEL for maternal (F0 -dams) and developmental toxicity (F1 -pups) was considered to be 20 mg/kg bw/day and 60 mg/kg bw/d, respectively. At 60 mg/kg bw/day, reduced food intake, reduced body weight and body weight gain were noted in the dams. The variation in the F1-pup development at 60 mg/kg bw/d are not considered to be of toxicological relevance as no such effects were seen in the F2 generation, receiving the substance over a significant longer period of time and over 2 generations.
Since no test item related changes were noted both in F1 male and female parental animals as well as no findings in F2 -pups were discovered the NOEL for both is considered to be > 60 mg/kg bw/d.
Effects on developmental toxicity
Description of key information
Olaflur neither possessed teratogenic properties nor caused developmental toxicity in the two tested species rat and rabbit, even tested at systemic toxic doses.
Effect on developmental toxicity: via oral route
- Dose descriptor:
- NOAEL
- 60 mg/kg bw/day
Additional information
Key studies:
1) Developmental, rat
In a developmental toxicity study (LTP, 2004), Olaflur (Amine fluoride 297) was administered to female CD/Crl:CD rats (25 mated animals/group) by oral gavage at dose levels of 0, 6, 20 or 60 mg/kg bw/day from days 6 through 17 of gestation. The NOAEL for maternal and prenatal developmental toxicity was considered to be 60 mg/kg bw/day. At 60 mg/kg bw/day, reduced food intake was noted in the dams. The test item Olaflur possessed no teratogenic properties, no increase in malformations and retardations was noted, not even at the materno-toxic dose. Marginal effects were noted at the materno-toxic dose (60 mg/kg bw/day) only in form of an increased incidence of soft tissue variations which however were well within the historic control range and not considered to indicate a embryotoxic effect.
2) Developmental, rat
In a developmental toxicity study (LTP, 2005) Olaflur (Amine fluoride 297 -103) was administered to pregnant CD/Crl:CD rats (20 /group, F0 -generation) by oral gavage at dose levels of 0, 6, 20 or 60 mg/kg bw/day from implantation (6th day of gestation) until weaning (the 21st day of lactation). After spontaneous delivery the F1-generation animals were examined and their development was observed employing parameters such as body weight gain, morphological landmarks and functional tests. Dams which did not deliver spontaneously were laparotomised on the 3rd day after the calculated day of delivery. The uterus was examined macroscopically and the implantation sites were determined. One male and one female rat of each litter and group (F1-generation; with a body weight nearest to the mean litter weight) were raised to maturity and mated at the age of 13 weeks. The males were sacrificed after the mating period. After spontaneous delivery, the pups (F2-generation) were weaned and their development was observed employing body weight gain. Dams which did not deliver spontaneously were laparotomised on the 3rd day after the calculated day of delivery. The uterus was examined macroscopically and the implantation sites were determined. The dams and pups were sacrificed after 3 lactation weeks.
The NOEL for maternal (F0 -dams) and developmental toxicity (F1 -pups) was considered to be 20 mg/kg bw/day and 60 mg/kg bw/d, respectively. At 60 mg/kg bw/day, reduced food intake, reduced body weight and body weight gain were noted in the dams. The variation in the F1-pup development at 60 mg/kg bw/d are not considered to be of toxicological relevance as no such effects were seen in the F2 generation, receiving the substance over a significant longer period of time and over 2 generations.
Since no test item related changes were noted both in F1 male and female parental animals as well as no findings in F2 -pups were discovered the NOEL for both is considered to be > 60 mg/kg bw/d.
3) Developmental, rabbit
In a developmental toxicity study (LTP, 2004), Dectaflur (Amine fluoride 335) was administered to female Himalayan rabbits (24 mated animals/group) by oral gavage at dose levels of 0, 6, 20 or 60 mg/kg bw/day from days 6 through 20 of gestation.
The NOAEL for maternal and prenatal developmental toxicity was considered to be 20 and 60 mg/kg bw/day, respectively.
At 60 mg/kg bw/day, pilo-erection and diarrhoea were noted in 2 of 21 dams. In addition, reductions were noted for the body weight, body weight gain and food Intake. Necropsy revealed a dilated gall bladder in 5 of 21 dams and a dilated Vena cava caudalis in 2 of 21 dams. The changes are considered to be test item related as these changes were only observed in the high dose. Moreover, in fetuses at 60 mg/kg bw/day, slight but statistically significant increases were noted for skeletal variations (incidence of sternebra(e) fused and total variations). However, these findings were well within the normal background range. No test item-related increase was noted in the incidence of malformations, variations and retardations at any of the tested doses.
In conclusion, the test item Dectaflur possessed no teratogenic properties, even tested at systemic toxic doses.
Supportive studies:
Seg II rat
In a Seg II developmental toxicity study (Menley & James 1973) Amine fluorides 297/242 were administered orally to mated Long-Evans rats from day 6 through day 15 of gestation. Dose levels of 1.0, 5.0, and 25.0 mg/kg bw/day were administered at a volume of 10 mL/kg bw/day in a vehicle of 0.25 % methylcellulose. The control group received the vehicle only. There were no adverse effects upon maternal body weight, pregnancy rate, mortality, early deliveries or abortions, implantation efficiency, fetal size, fetal sex, or malformations. There was no biologic or toxicologic significance attached to the incidence of ossification variations observed in this study.
There was a statistically significant Increase (p<0.05) from control in the incidence of resorptions in the high-dose group, but this did not effect any other parameter linked to reproduction (e.g. total fetal size, abortions or early deliveries) and was not confirmed in developmental studies with Olaflur in rats and rabbits.
Seg II, rabbit
In a Seg II developmental toxicity study (Menley & James 1973) Amine fluorides 297/242 were administered orally to mated sexually mature New Zealand White female rabbits from day 7 through day 19 of gestation (day 0 = day of mating). Dose levels of 1, 5, and 25 mg/kg bw/day were administered at a volume of 1 mL/kg bw/day in a vehicle of 0.25 % methylcellulose. The control group received the vehicle only. There were no adverse effects upon pregnancy rate, incidences of early deliveries and abortions, fetal size, fetal sex, or ossification variations which could be attributed to the administration of Amine fluoride 297/242. Four fetuses in the treatment groups (two low, one mid, and one high) were observed to be malformed. This low incidence was not considered to express evidence of a teratogenic effect resulting from the administration of the compound. Maternal toxicity was expressed as reduced body weight gain and weight loss in the high-dose group, and increased maternal and fetal mortality in the mid and high-dose groups. These effects were attributed to a secondary toxemia resulting from the antibacterial properties of the amine fluorides against gram-positive bacteria followed by an overgrowth of gram-negative bacteria.
Seg III, rat
In a Seg III developmental toxicity study (Menley & James 1973) Amine fluorides 297/242 were administered orally to mated Long-Evans rats from day 15 of gestation through day 21 of lactation. Dose levels of 1.0, 5.0, and 25.0 mg/kg bw/day were administered at a volume of 10 mL/kg bw/day in a vehicle of 0.25 % methylcellulose. The control group received the vehicle only.
There were no adverse effects upon pregnancy rate, maternal mortality, prenatal or postnatal offspring viability, percent of litters weaned, mean offspring weights., sex ratios, or soft-tissue malformations. Some slight effects concerning intrauterine deaths and postnatal viability were observed, however, these effects were not dose dependent and not considered test item related, respectively.
Justification for classification or non-classification
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. Based on available data on toxicity to reproduction, the test item is not classified according to Regulation (EC) No 1272/2008 (CLP), as amended for the eighth time in Regulation (EU) No 2016/918.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.